scispace - formally typeset
Open AccessJournal ArticleDOI

Opportunities for Host-targeted Therapies for Malaria

TLDR
New opportunities for host-targeted therapeutics for malaria and the potential to harness drug polypharmacology to simultaneously target multiple host pathways using a single drug intervention are discussed.
About
This article is published in Trends in Parasitology.The article was published on 2018-10-01 and is currently open access. It has received 41 citations till now. The article focuses on the topics: Plasmodium vivax & Cerebral Malaria.

read more

Citations
More filters
Journal ArticleDOI

Ferrocene-Based Compounds with Antimalaria/Anticancer Activity

TL;DR: This review will be focused on compounds with ferrocene moieties that exhibit either an anticancer or antimalarial activity.
Journal ArticleDOI

Blood-Brain Barrier in Cerebral Malaria: Pathogenesis and Therapeutic Intervention.

TL;DR: The mechanisms associated with the disruption of the BBB are reviewed and the current, still limited, knowledge on the contribution of different cell types, microparticles, and the kynurenine pathway in the regulation of BBB dysfunction is discussed, and how these molecules could be used as potential new therapeutic targets.
Journal ArticleDOI

Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection.

TL;DR: It is revealed that various host intracellular protein trafficking pathways are subverted by Plasmodium parasites during the liver stage and provide new insights into their manipulation for growth and development.
Journal ArticleDOI

Brain Endothelium: The “Innate Immunity Response Hypothesis” in Cerebral Malaria Pathogenesis

TL;DR: Uncovering mechanisms of BVE involvement in sensing Plasmodium infection, recruiting of immune cells and directing immune effector functions could reveal pharmacological targets to promote BBB protection with potential applications in CM clinical management.
Journal ArticleDOI

Development of Chemical Entities Endowed with Potent Fast-Killing Properties against Plasmodium falciparum Malaria Parasites.

TL;DR: The medicinal chemistry efforts focused on a cGMP-dependent protein kinase (PKG) inhibitor scaffold are described, leading to the identification of novel chemical entities with very potent, similar to artemisinins, fast-killing potency against asexual blood stages that cause disease, and activity against gametocyte activation that is required for transmission.
References
More filters
Journal ArticleDOI

Endoplasmic reticulum stress in liver disease

TL;DR: The unfolded protein response is activated in several liver diseases; including obesity associated fatty liver disease, viral hepatitis, and alcohol-induced liver injury, raising the possibility that ER stress-dependent alteration in lipid homeostasis is the mechanism that underlies the steatosis.
Journal ArticleDOI

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

TL;DR: A recombinant vaccine based on fusion of the circumsporozoite protein and HBsAg plus a potent adjuvant can protect against experimental challenge with P. falciparum malaria.
Journal ArticleDOI

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

TL;DR: It is concluded that increased TNF production is a normal host response to P falciparum infection, but that excessive levels of production may predispose to cerebral malaria and a fatal outcome.
Journal ArticleDOI

Tumor Necrosis Factor and Disease Severity in Children with Falciparum Malaria

TL;DR: The level of tumor necrosis factor is frequently increased in patients with severe falciparum malaria, particularly in those with cerebral malaria or hypoglycemia, and whether it is important in the pathogenesis of the signs and symptoms of the disease requires further study.
Journal ArticleDOI

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

TL;DR: Quantitative analysis revealed complex and often unexpected interactions between protein kinases and kinase inhibitors, with a wide spectrum of promiscuity, revealing how large-scale profiling can identify multitargeted inhibitors of specific, diverse kinases.
Related Papers (5)